Naturally Occurring Escape Mutants of Hepatitis B Virus with Various Mutations in the S Gene in Carriers Seropositive for Antibody to Hepatitis B Surface Antigen

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1994 Apr 1

PMID 8139044

Citations 80

Authors

K Yamamoto

M Horikita

F Tsuda

K Itoh

Y Akahane

S Yotsumoto

H Okamoto

Y Miyakawa

M Mayumi

Affiliations

Soon will be listed here.

Abstract

Hepatitis B virus (HBV) DNA was extracted from sera of six carriers with hepatitis B e antigen as well as antibody to hepatitis B surface antigen and sequenced within the pre-S regions and the S gene. HBV DNA clones from five of these carriers had point mutations in the S gene, resulting in conversion from Ile-126 or Thr-126 of the wild-type virus to Ser-126 or Asn-126 in three carriers and conversion from Gly-145 to Arg-145 in three of them; clones with Asn-126 or Arg-145 were found in one carrier. All 12 clones from the other carrier had an insertion of 24 bp encoding an additional eight amino acids between Thr-123 and Cys-124. In addition, all or at least some of the HBV DNA clones from these carriers had in-phase deletions in the 5' terminus of the pre-S2 region. These results indicate that HBV escape mutants with mutations in the S gene affecting the expression of group-specific determinants would survive in some carriers after they seroconvert to antibody against surface antigen. Carriers with HBV escape mutants may transmit HBV either by donation of blood units without detectable surface antigen or through community-acquired infection, which would hardly be prevented by current hepatitis B immuneglobulin or vaccines.

Citing Articles

Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions.

Zhang J, Wang Q, Yuan W, Li J, Yuan Q, Zhang J J Virol. 2024; 98(8):e0192923.

PMID: 39078152 PMC: 11334434. DOI: 10.1128/jvi.01929-23.

Immune-Escape Mutations Are Prevalent among Patients with a Coexistence of HBsAg and Anti-HBs in a Tertiary Liver Center in the United States.

Ali M, Shah P, Rehman K, Kaur S, Holzmayer V, Cloherty G Viruses. 2024; 16(5).

PMID: 38793596 PMC: 11125813. DOI: 10.3390/v16050713.

High Frequency of Antiviral Resistance Mutations in HBV Genotypes A2 and H: Multidrug Resistance Strains in Mexico.

Jose-Abrego A, Roman S, Pinho J, Gomes-Gouvea M, Panduro A J Clin Transl Hepatol. 2023; 11(5):1023-1034.

PMID: 37577226 PMC: 10412697. DOI: 10.14218/JCTH.2022.00135S.

Rapid quantification assay of hepatitis B virus DNA in human serum and plasma by Fully Automated Genetic Analyzer μTASWako g1.

Watanabe M, Toyoda H, Kawabata T PLoS One. 2023; 18(2):e0278143.

PMID: 36758029 PMC: 9910706. DOI: 10.1371/journal.pone.0278143.

Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis.

Im Y, Jagdish R, Leith D, Kim J, Yoshida K, Majid A Lancet Gastroenterol Hepatol. 2022; 7(10):932-942.

PMID: 35961359 PMC: 9630161. DOI: 10.1016/S2468-1253(22)00201-1.

References

Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y . e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976; 294(14):746-9. DOI: 10.1056/NEJM197604012941402. View

Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y . Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol. 1990; 64(3):1298-303. PMC: 249247. DOI: 10.1128/JVI.64.3.1298-1303.1990. View

Brown S, Howard C, Zuckerman A, Steward M . Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet. 1984; 2(8396):184-7. DOI: 10.1016/s0140-6736(84)90479-3. View

Okamoto H, Imai M, Usuda S, Tanaka E, Tachibana K, Mishiro S . Hemagglutination assay of polypeptide coded by the pre-S region of hepatitis B virus DNA with monoclonal antibody: correlation of pre-S polypeptide with the receptor for polymerized human serum albumin in serums containing hepatitis B antigens. J Immunol. 1985; 134(2):1212-6. View

Neurath A, Kent S, Strick N, Taylor P, Stevens C . Hepatitis B virus contains pre-S gene-encoded domains. Nature. 1985; 315(6015):154-6. DOI: 10.1038/315154a0. View

Tiollais P, Pourcel C, Dejean A . The hepatitis B virus. Nature. 1985; 317(6037):489-95. DOI: 10.1038/317489a0. View

Steinhauer D, Holland J . Direct method for quantitation of extreme polymerase error frequencies at selected single base sites in viral RNA. J Virol. 1986; 57(1):219-28. PMC: 252718. DOI: 10.1128/JVI.57.1.219-228.1986. View

Paterlini P, Gerken G, Nakajima E, Terre S, DErrico A, Grigioni W . Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med. 1990; 323(2):80-5. DOI: 10.1056/NEJM199007123230202. View

Carman W, Zanetti A, Karayiannis P, Waters J, MANZILLO G, Tanzi E . Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990; 336(8711):325-9. DOI: 10.1016/0140-6736(90)91874-a. View

10.

Moriyama K, Nakajima E, Hohjoh H, ASAYAMA R, Okochi K . Immunoselected hepatitis B virus mutant. Lancet. 1991; 337(8733):125. DOI: 10.1016/0140-6736(91)90793-o. View

11.

Gerken G, Kremsdorf D, Capel F, Petit M, Dauguet C, Manns M . Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection. Virology. 1991; 183(2):555-65. DOI: 10.1016/0042-6822(91)90984-j. View

12.

Schaller H, Fischer M . Transcriptional control of hepadnavirus gene expression. Curr Top Microbiol Immunol. 1991; 168:21-39. DOI: 10.1007/978-3-642-76015-0_2. View

13.

Schodel F, Moriarty A, Peterson D, Zheng J, Hughes J, Will H . The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol. 1992; 66(1):106-14. PMC: 238265. DOI: 10.1128/JVI.66.1.106-114.1992. View

14.

McMahon G, Ehrlich P, Moustafa Z, McCarthy L, Dottavio D, Tolpin M . Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology. 1992; 15(5):757-66. DOI: 10.1002/hep.1840150503. View

15.

Santantonio T, Jung M, Schneider R, Fernholz D, Milella M, Monno L . Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. Virology. 1992; 188(2):948-52. DOI: 10.1016/0042-6822(92)90559-8. View

16.

Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y . Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun. 1992; 184(3):1152-7. DOI: 10.1016/s0006-291x(05)80003-8. View

17.

Harrison T, Hopes E, Oon C, Zanetti A, Zuckerman A . Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol. 1991; 13 Suppl 4:S105-7. DOI: 10.1016/0168-8278(91)90037-c. View

18.

Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K . Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res. 1992; 32(3):264-8. DOI: 10.1203/00006450-199209000-00002. View

19.

Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F . Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang. 1992; 63(2):107-11. DOI: 10.1111/j.1423-0410.1992.tb02495.x. View

20.

Ohnuma H, Machida A, Okamoto H, Tsuda F, Sakamoto M, Tanaka T . Allelic subtypic determinants of hepatitis B surface antigen (i and t) that are distinct from d/y or w/r. J Virol. 1993; 67(2):927-32. PMC: 237446. DOI: 10.1128/JVI.67.2.927-932.1993. View